Streetbeat News

Stock Prices

DARE

Dare Bioscience announced positive safety and tolerability data from a study of its investigational product DARE-VVA1.

Portfolio Pulse from Charles Gross

June 09, 2023 | 12:03 pm

WING

In the last quarter, Wingstop (NASDAQ:WING) received 6 somewhat bullish, 7 indifferent, and 1 somewhat bearish analyst ratings. The average 12-month price target for the stock is $207.93, up 10.85% from the previous average of $187.58.

Portfolio Pulse from Benzinga Insights

June 09, 2023 | 12:03 pm

SFT

Shift Technologies, a used car e-commerce platform, has named Ayman Moussa as its new CEO and board member. Moussa brings extensive experience in the automotive industry and is expected to drive the company's growth.

Portfolio Pulse from Charles Gross

June 09, 2023 | 12:02 pm

YUM

In the last quarter, Yum Brands (NYSE:YUM) received 1 bullish, 4 somewhat bullish, and 5 indifferent analyst ratings. The average price target is $151.2, up 1.99% from the previous target of $148.25, implying an upside compared to the current price of $133.2.

Portfolio Pulse from Benzinga Insights

June 09, 2023 | 12:01 pm

HWKN

INTR

MLM

USAP

VMC

The article lists the top 5 overbought materials stocks that may crash this month, based on their RSI values. The stocks mentioned are Inter & Co, Inc. (INTR), Hawkins, Inc. (HWKN), Universal Stainless & Alloy Products, Inc. (USAP), Martin Marietta Materials, Inc. (MLM), and Vulcan Materials Company (VMC).

Portfolio Pulse from Lisa Levin

June 09, 2023 | 11:50 am

GM

TSLA

General Motors (GM) shares surged in premarket trading after announcing a partnership with Tesla, allowing GM EV customers access to Tesla's Supercharger network. The strategic move is expected to help GM expand its charging access and support its EV transformation.

Portfolio Pulse from Shanthi Rexaline

June 09, 2023 | 11:47 am

VOR

Vor Bio (NASDAQ:VOR) announced successful primary engraftment of trem-cel in the first five acute myeloid leukemia patients in its Phase 1/2a VBP101 study. The data was presented at the European Hematology Association 2023 Congress in Frankfurt, Germany.

Portfolio Pulse from Charles Gross

June 09, 2023 | 11:38 am

APRE

ERAS

STSA

Insiders at Satsuma Pharmaceuticals, Erasca, and Aprea Therapeutics have been aggressively buying shares, indicating confidence in their respective companies. Satsuma Pharmaceuticals recently announced FDA acceptance of its STS101 migraine treatment, while Erasca discontinued its ERAS-007 programs, and Aprea Therapeutics posted a narrower quarterly loss.

Portfolio Pulse from Lisa Levin

June 09, 2023 | 11:30 am

CHPT

GM

TSLA

Nasdaq futures resist Fed rate anxiety, supported by Tesla's agreement with General Motors to allow GM's EVs to charge at Tesla Supercharger locations. Tesla shares rallied over 4.5% in premarket trading, while GM was up about 3.50%. ChargePoint Holdings fell over 5% in reaction to the Tesla-GM partnership.

Portfolio Pulse from Shanthi Rexaline

June 09, 2023 | 11:27 am

SIEN

Sientra shares surged 83.9% in pre-market trading after announcing FDA-clearance of its next-generation AlloX2 Pro Tissue Expander. Other pre-market gainers include Advanced Health Intelligence, ContraFect Corporation, and Sonoma Pharmaceuticals, while Elevation Oncology, Baosheng Media Group, and Planet Labs were among the losers.

Portfolio Pulse from Lisa Levin

June 09, 2023 | 11:22 am